CeramTec will soon undergo a changing of the guard.

Dr. Hadi Saleh is entering the home stretch of his directorial tenure: After 10 years as managing director, including seven years as CEO, Dr. Saleh will step back from his daily administrative duties in July and assume a non-executive director position on the company’s Supervisory Board.

Dr. Saleh’s successor will be Dr. Carla Kriwet, who will join CeramTec in July and gradually transition to her role as CEO and president of Medical by the end of the year (at the latest).

Dr. Kriwet has significant experience in leading successful global businesses at the forefront of their industries. She’s been CEO of BSH Haus-geräte GmbH, chief executive of Fresenius Medical Care AG, and CEO of the Connected Care division at Philips N.V.

Drs. Saleh and Kriwet will work closely together to ensure a smooth and effective transition for CeramTec and all stakeholders before the end of this year.

CeramTec is a global medtech platform with a focus on high-performance ceramics (HPC) solutions, and specializes in developing, manufacturing and selling parts, ceramic components and products. With more than a century of developmental and production experience in the HPC industry, CeramTec engineers advanced ceramics for use in various applications.

HPC from CeramTec are used in numerous areas, including critical medical applications such as hip replacements, other orthopedic implants, dental implants, and medical equipment, and industries including mobility, electronics, and in other industrial applications. With production sites and subsidiaries in Europe, North America, South America, and Asia, CeramTec maintains its presence around the globe as a manufacturer and supplier. The company employs about 3,800 workers globally and is headquartered in Plochingen, near Stuttgart, Germany. CeramTec generated €746 million euros in 2024 revenue.